Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04669587
Title ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study) (ENZENO)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors EnhancedBio USA Inc.
Indications

breast adenocarcinoma

Therapies

ZB716

Palbociclib + ZB716

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Swedish Cancer Institute Recruiting Seattle Washington 98104 United States Details
National Cancer Center Recruiting Goyang-si Gyeonggi-do 10408 Korea, Republic of Details
CHA Bundang Medical Center, CHA University Recruiting Seongnam-si 13496 Korea, Republic of Details
Korea University Anam Hospital Recruiting Seoul 02841 Korea, Republic of Details
Kangbuk Samsung Hospital Recruiting Seoul 03181 Korea, Republic of Details
Severance Hospital, Yonsei University Health System Recruiting Seoul 03722 Korea, Republic of Details
Asan Medical Center Recruiting Seoul 05505 Korea, Republic of Details
The Catholic University of Korea, Seoul St. Mary's Hospital Recruiting Seoul 06591 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field